Alemtuzumab Intravenous and Hypaque Meglumine
Determining the interaction of Alemtuzumab Intravenous and Hypaque Meglumine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Hypaque Meglumine (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Hypaque-76
- Alemtuzumab Intravenous-Hypaque-Cysto
- Alemtuzumab Intravenous-Hyper-Sal inhalation
- Alemtuzumab Intravenous-Hyperhep B
- Alemtuzumab Intravenous-HyperHEP B S/D
- Alemtuzumab Intravenous-Hyperlyte CR
- Hypaque Meglumine-Alenaze-D
- Hypaque Meglumine-Alendronate
- Hypaque Meglumine-Alendronate and cholecalciferol
- Hypaque Meglumine-Alendronate Effervescent Tablets
- Hypaque Meglumine-Alendronate Oral Solution
- Hypaque Meglumine-Alendronate Sodium